Table 2.
The most detrimental and protective factors for the three thyroid diseases.
| Trait | Exposure | IVW | MR-Egger | Weighted median | |||
|---|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | ||
| Thyroid cancer | Aspartate | 7.41(1.51-36.27) | 0.013 | 89.24(1.01-7882.92) | 0.188 | 6.67(0.80-55.52) | 0.079 |
| Thyroid cancer | C-glycosyltryptophan | 0.04(0.00-0.29) | 0.001 | 0.02(0.00-14.33) | 0.261 | 0.04(0.00-0.88) | 0.041 |
| Graves’ disease | Kynurenine | 2.69(1.08-6.66) | 0.033 | 2.10(0.21-21.28) | 0.533 | 1.05(0.26-4.19) | 0.945 |
| Graves’ disease | 4-androsten-3beta,17beta-diol disulfate 2 | 0.48(0.25-0.91) | 0.024 | 0.17(0.02-1.53) | 0.133 | 0.40(0.17-0.94) | 0.036 |
| Hashimoto thyroiditis | Alpha-ketoglutarate | 46.89(4.65-473.28) | 0.001 | 74.02(0.00-875286845) | 0.617 | 11.17(0.46-268.59) | 0.137 |
| Hashimoto thyroiditis | X-14189–leucylalanine | 0.31(0.15-0.64) | 0.001 | 0.40(0.11-1.50) | 0.209 | 0.34(0.13-0.92) | 0.033 |
IVW, inverse variance weighted.